REGULATION OF LH RECEPTORS AND PROGESTERONE SECRETION

LH 受体和孕酮分泌的调节

基本信息

  • 批准号:
    3485037
  • 负责人:
  • 金额:
    $ 12.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1978
  • 资助国家:
    美国
  • 起止时间:
    1978-07-01 至 1993-11-30
  • 项目状态:
    已结题

项目摘要

The goal of this research is to obtain a better understanding of the factors which regulate secretion of progesterone from the corpus luteum in order to develop better contraceptives and treat infertility. The proposed research has five specific aims. 1) To determine if mLH and mCG have different receptor-mediated actions in primate luteal cells, rhodamine-labeled hormones will be used to measure the lateral mobility of the receptor for LH by laser photobleach recovery. If mCG, but not mLH, immobilizes the receptor for LH in primate luteal cells, it will be determined if mCG also causes a greater increase in secretion of progesterone than mLH. The results of this study have very important implications for treatment of infertility. 2) To determine the follicular source of origin of the two types of steroidogenic luteal cells, lipophilic dyes will be used to specifically label thecal or granulosal cells in the preovulatory follicle or the corpus hemorrhagicum. Luteal tissue will be collected during the early, mid and late luteal phases of the estrous cycle and the origins of large and small luteal cells determined based on the presence of the fluorescent, lipophilic dyes. 3) To elucidate the role of growth factors in controlling the division, differentiation and function of luteal cells, the number of receptors for IGF-I, IGF-II, EGF and FGF will be determined at different stages of the estrous cycle. In situ hybridization of cRNA probes will be used to localize mRNA for the growth factors to determine which cell types synthesize these factors. Subsequent studies will evaluate the actions of growth factors and control of their secretion in purified preparations of luteal cells. 4) To study control of steroidogenesis in the two types of steroidogenic luteal cells, initial studies will evaluate the lipoprotein pathway. The role of calcium will be studied using "patch clamp" procedures to evaluate the number and activity of calcium channels and fluorescent dyes will be used to monitor intracellular calcium shifts. Inhibitors and stimulators of calmodulin and protein kinase C activity will be used to evaluate the activity of these second messengers. 5) Finally, numbers of luteal cells, their receptor content and responsiveness to various hormones will be determined in the two steroidogenic luteal cell types to define at the cellular level changes occurring during transition of the corpus luteum of the estrous cycle to the corpus luteum of pregnancy.
这项研究的目的是为了获得更好的理解

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TORRANCE M NETT其他文献

TORRANCE M NETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TORRANCE M NETT', 18)}}的其他基金

Physiological Mechanisms Underlying Heightened Responsiveness of Gonadotropes to
促性腺激素反应增强的生理机制
  • 批准号:
    7947530
  • 财政年份:
    2010
  • 资助金额:
    $ 12.68万
  • 项目类别:
SYMPOSIUM AND STATE-OF-THE-ART LECTURES
研讨会和最先进的讲座
  • 批准号:
    2201756
  • 财政年份:
    1992
  • 资助金额:
    $ 12.68万
  • 项目类别:
BIOMEDICAL RESEARCH SUPPORT
生物医学研究支持
  • 批准号:
    3515289
  • 财政年份:
    1987
  • 资助金额:
    $ 12.68万
  • 项目类别:
BIOMEDICAL RESEARCH SUPPORT
生物医学研究支持
  • 批准号:
    3515288
  • 财政年份:
    1986
  • 资助金额:
    $ 12.68万
  • 项目类别:
SHORT-TERM TRAINING STUDENTS IN HEALTH SCHOOLS
保健学校短期培训学生
  • 批准号:
    3545638
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:
SHORT-TERM TRAINING STUDENTS IN HEALTH SCHOOLS
保健学校短期培训学生
  • 批准号:
    3545636
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
健康专业学校的学生
  • 批准号:
    3545643
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:
SHORT-TERM TRAINING STUDENTS IN HEALTH SCHOOLS
保健学校短期培训学生
  • 批准号:
    3545640
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
健康专业学校的学生
  • 批准号:
    3545637
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
健康专业学校的学生
  • 批准号:
    3545641
  • 财政年份:
    1985
  • 资助金额:
    $ 12.68万
  • 项目类别:

相似海外基金

L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
  • 批准号:
    10668210
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
  • 批准号:
    10603554
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
  • 批准号:
    10684558
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
  • 批准号:
    10628914
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
  • 批准号:
    10815882
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
  • 批准号:
    10734121
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
  • 批准号:
    10628911
  • 财政年份:
    2023
  • 资助金额:
    $ 12.68万
  • 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
  • 批准号:
    2200474
  • 财政年份:
    2022
  • 资助金额:
    $ 12.68万
  • 项目类别:
    Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
  • 批准号:
    452107
  • 财政年份:
    2021
  • 资助金额:
    $ 12.68万
  • 项目类别:
    Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
  • 批准号:
    10399417
  • 财政年份:
    2021
  • 资助金额:
    $ 12.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了